Horton R, Smith R.
Time to register randomised trials. The case is now unanswerable [Editorial]. BMJ. 1999;319:865.-6CrossRef
Chalmers I. Unbiased, relevant, and reliable assessments in health care: important progress during the past century, but plenty of scope for doing better [Editorial]. BMJ. 1998;317:1167.-8
Lilienfeld AM. Ceteris paribus: the evolution of the clinical trial. Bull Hist Med. 1982;56:1.-18
Streptomycin treatment of pulmonary tuberculosis. Medical Research Council. Br Med J. 1948; 769-82.
Statement by Michael A. Friedman, MD, Lead Deputy Commissioner, Food and Drug Administration, Department of Health and Human Services, before the Committee on Government Reform and Oversight, U.S. House of Representatives, 22 April 1998.http://www.fda.gov/ola/1998/therapy.htm
. Accessed 1 June 2000.
Simes RJ. Publication bias: the case for an international registry of clinical trials. J Clin Oncol. 1986;4:1529.-41
Meinert CL. Toward prospective registration of clinical trials. Control Clin Trials. 1988;9:1.-5
Dickersin K. Report from the panel on the Case for Registers of Clinical Trials at the Eighth Annual Meeting of the Society for Clinical Trials. Control Clin Trials. 1988;9:76.-81
Boissel JP, Haugh MC. Clinical trial registries and ethics review boards: the results of a survey by the FICHTRE project. Fundam Clin Pharmacol. 1997;11:281.-4
Chalmers I. Underreporting research is scientific misconduct. JAMA. 1990;263:1405.-8
Haynes B, Haines A. Barriers and bridges to evidence based clinical practice. BMJ. 1998;317:273.-6
Roberts I. An amnesty for unpublished trials. One year on, many trials are unregistered and the amnesty remains open [Editorial]. BMJ. 1998;317:763.-4
Sim I, Rennels G. A trial bank model for the publication of clinical trials. Proc Annu Symp Comput Appl Med Care.. 1995;863.-7
Section 2317, Health Omnibus Programs Extension Act of 1988, Public Law 100-607.
Section 113, Information Program on Clinical Trials for Serious or Life-Threatening Diseases. Food and Drug Administration Modernization Act of 1997, Public Law 105-115.
Easterbrook PJ. Directory of registries of clinical trials. Stat Med. 1992;11:345.-59
Tonks A. Registering clinical trials. BMJ. 1999;319:1565.-8
Dickersin K, Manheimer E. The Cochrane Collaboration: evaluation of health care and services using systematic reviews of the results of randomized controlled trials. Clin Obstet Gynecol. 1998;41:315.-31
International collaborative group on clinical trial registries. Position paper and consensus recommendations on clinical trial registries. Ad Hoc Working Party of the International Collaborative Group on Clinical Trials Registries. Clin Trials Metaanal. 1993; 28:255-66.International collaborative group on clinical trial registries. Position paper and consensus recommendations on clinical trial registries. Clin Trials Metaanal. 1993;28:255.-66
Rennie D. Fair conduct and fair reporting of clinical trials [Editorial]. JAMA. 1999;282:1766.-8
Spilker B. Guide to Clinical Trials. Philadelphia Lippincott–Raven1996;816.-9
Friedman LM, Furberg CD, DeMets DL. Fundamentals of Clinical Trials. 3rd ed. New York: Springer; 1998:333-42.
Nowak R. Problems in clinical trials go far beyond misconduct. Science. 1994;264:1538.-41
Chalmers I. The Cochrane collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care. Ann N Y Acad Sci. 1993;703:156.-65
Morris RD, Lau J, Arena NJ, Nardine FE, Chalmers TC. A clinical trials database as a research tool in health care. Online J Curr Clin Trials. 1992; Doc. No. 14.
Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al.. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996;276:637.-9
Checklist of information for inclusion in reports of clinical trials. The Asilomar Working Group on Recommendations for Reporting of Clinical Trials in the Biomedical Literature. Ann Intern Med. 1996; 124:741-3.The Asilomar Working Group on Recommendations for Reporting of Clinical Trials in the Biomedical Literature. Checklist of information for inclusion in reports of clinical trials. Ann Intern Med. 1996;124:741.-3
Mansour EG. Barriers to clinical trials. Part III: Knowledge and attitudes of health care providers. Cancer. 1994;74:2672.-5
Fleming ID. Barriers to clinical trials. Part I: Reimbursement problems. Cancer. 1994;74:2662.-5
Schain WS. Barriers to clinical trials. Part II: Knowledge and attitudes of potential participants. Cancer. 1994;74:2666.-71
Corbett F, Oldham J, Lilford R. Offering patients entry in clinical trials: preliminary study of the views of prospective participants. J Med Ethics. 1996;22:227.-31
Featherstone K, Donovan JL. Random allocation or allocation at random? Patients' perspectives of participation in a randomized controlled trial. BMJ. 1998;317:1177.-80
Moher D. Facilitating clinical research in the 1990s and beyond: challenges facing clinical trial registers. Fundam Clin Pharmacol. 1995;9:381.-3
McCray AT, Ide NC. Design and implementation of a national clinical trials registry. J Am Med Inform Assoc. 2000;7:313.-23
McCray AT. A national resource for information on clinical trials. National Forum. 1999;79:19.-21
Lindberg DA, Humphreys BL, McCray AT. The Unified Medical Language System. Methods Inf Med. 1993;32:281.-91